USFDA issues final guidance on voluntary recalls
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
Covaxin is not approved in the USA for any age group
The product will be manufactured at Lupin’s facility in Pithampur, India
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
Subscribe To Our Newsletter & Stay Updated